beta-Hydroxybutyrate is an alternative substrate for the fetal sheep brain

Prior research has shown that the brain can use substrates other than glucose for energy in postnatal life. However, no evidence existed for this in fetal stages. Established knowledge indicated that glucose is the primary energy source for the developing brain. That uncertainty drove investigation into whether alternative substrates might be used in utero. This gap motivated experiments to test substrate uptake in fetal sheep. No prior work had resolved if ketone bodies like beta-hydroxybutyrate could serve as alternative fuels. The fetal brain's metabolic flexibility remained unclear. This study aimed to address that knowledge gap directly.

The goal was to determine if the fetal brain could take up substrates other than glucose. Specifically, the researchers focused on beta-hydroxybutyrate and lactate. They wanted to test whether these could serve as alternative energy sources in utero. The study aimed to clarify if the fetal sheep brain could utilize ketone bodies. This was important because glucose availability may be limited during fetal development. The researchers hypothesized that alternative substrates might be used when glucose is scarce. They sought to measure brain uptake of beta-hydroxybutyrate and lactate. The purpose was to expand understanding of fetal brain metabolism.

The study involved 10 chronically catheterized fetal sheep at 135–141 days gestation. Researchers infused beta-hydroxybutyrate and lactate for two hours. They measured arterial blood glucose and beta-hydroxybutyrate concentrations. Brain butyrate/oxygen quotients were calculated at infusion endpoints. The team used catheters to collect blood samples from the fetuses. They analyzed the data to assess brain uptake of the substrates. No evidence of lactate uptake was found in the brain samples. The study focused on comparing glucose levels with substrate uptake patterns.

Brain uptake of beta-hydroxybutyrate was observed in five fetuses with low arterial glucose. In five fetuses with higher glucose, the brain produced beta-hydroxybutyrate. Brain butyrate/oxygen quotients correlated with arterial glucose (r2 = 0.72, P < 0.01). No correlation was found between butyrate/oxygen quotients and arterial beta-hydroxybutyrate levels. Lactate was not taken up by the brain in any of the fetuses. The highest uptake occurred when glucose was low and beta-hydroxybutyrate was high. These findings suggest substrate flexibility in the fetal brain. The results highlight a conditional use of ketone bodies in utero.

The authors suggest that the fetal brain may take up substrates other than glucose in vivo. This is the first evidence of such alternative substrate use in fetal life. The findings show that beta-hydroxybutyrate uptake depends on glucose availability. The brain appears to use ketone bodies when glucose is low. No uptake of lactate was observed in the study. The study does not claim that ketone bodies are essential for fetal brain function. The results indicate conditional metabolic flexibility. These conclusions are based directly on the observed data patterns.